In cancer, hyperactivation of CDK4/6 due to mutation, gene amplification, or mitogen-independent signaling often bypasses Rb-mediated cell-cycle checkpoints, enabling uncontrolled proliferation.2 This evidence concerns the gene RB1 and cancer.